±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 990  |  »Ø¸´: 4
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ÑÌÔÆÌýÓê

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

½ð³æ

[ÇóÖú] Çó·­ÒëÒ»¶ÎÓ¢ÎÄÎÄÏ×(Óлú»¯Ñ§)

In addition to their potential as an antitussive target, Sig-Rs have been implicated in a wide range of physiological functions and thus represent a unique therapeutic target for disorders such as depression, schizophrenia, and Parkinson¡¯s
disease (41¨C44). Although the precise role of Sig-Rs is not well understood, it is widely believed that the effects of Sig-Rs can be attributed to their modulation of other receptor types. This neuromodulatory role has complicated research on Sig-Rs and underscores the benefit of finding new compounds to modulate
these receptors and probe their function (43, 44). Table 1 summarizes
the overall yields for the initial library efforts as well as exploratory screening for ¦Ê opioid receptor (KOR), sigma 1, and sigma 2 receptor binding (Ki values) for these compounds.

» ²ÂÄãϲ»¶

ÄîÄî²»Íü£¬±ØÓлØÏì
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

ÑÌÔÆÌýÓê(½ð±Ò+10, ·­ÒëEPI+1): 1 2011-07-19 12:25:35
ÇëÄã°´ÕÕ°æ¹æÈ·¶¨½ð±ÒÊýÁ¿£¬Ì«ÉÙÁËÒ»°ã²»Ò׵õ½Ó¦Öú
2Â¥2011-07-19 08:13:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

In addition to their potential as an antitussive target, Sig-Rs have been implicated in a wide range of physiological functions and thus represent a unique therapeutic target for disorders such as depression, schizophrenia, and Parkinson¡¯s disease (41¨C44). Although the precise role of Sig-Rs is not well understood, it is widely believed that the effects of Sig-Rs can be attributed to their modulation of other receptor types. This neuromodulatory role has complicated research on Sig-Rs and underscores the benefit of finding new compounds to modulate these receptors and probe their function (43, 44). Table 1 summarizes the overall yields for the initial library efforts as well as exploratory screening for ¦Ê opioid receptor (KOR), sigma 1, and sigma 2 receptor binding (Ki values) for these compounds.
126´Ê=50½ð±Ò£¡
3Â¥2011-07-19 10:50:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

In addition to their potential as an antitussive target, Sig-Rs have been implicated in a wide range of physiological functions and thus represent a unique therapeutic target for disorders such as depression, schizophrenia, and Parkinson¡¯s disease (41¨C44). ³ýÁË×÷ΪDZÔÚµÄÕò¿È°Ð±ê£¬Sig-RÓëÐí¶àÉúÀí¹¦ÄÜÏà¹Ø£¬Òò¶øÓпÉÄÜ×÷ΪijЩ¼²²¡ÈçÒÖÓôÖ¢¡¢¾«Éñ·ÖÁÑÖ¢ºÍÅÁ½ðÉ­Êϲ¡µÈµÄÖÎÁưбꡣ
4Â¥2011-07-19 16:47:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡ï ¡ï
Mally89(½ð±Ò+2): ¸ÐлӦÖú£¡~ÐÁ¿àÁË£¡~ 2011-07-23 22:09:02
Although the precise role of Sig-Rs is not well understood, it is widely believed that the effects of Sig-Rs can be attributed to their modulation of other receptor types. ¾¡¹Ü¶ÔÓÚSig-RµÄÃ÷È·½ÇÉ«ÉÐδÍêÈ«²ûÃ÷£¬µ«±È½Ï¹«ÈϵÄÊÇSig-RµÄЧӦ¿ÉÒÔ¹é½áÓÚËüÃÇ¶ÔÆäËûÊÜÌåÀàÐ͵ĵ÷½Ú¡£This neuromodulatory role has complicated research on Sig-Rs and underscores the benefit of finding new compounds to modulate these receptors and probe their function (43, 44). Sig-RÕâÖÖÉñ¾­µ÷½Ú½ÇÉ«µÄ¸´ÔÓÑо¿Í¹ÏÔ·¢ÏÖµÄÄܹ»µ÷½ÚÕâЩÊÜÌ岢̽Ë÷ÕâЩÊÜÌ幦ÄܵÄл¯ºÏÎïµÄÒæ´¦¡£Table 1 summarizes the overall yields for the initial library efforts as well as exploratory screening for ¦Ê opioid receptor (KOR), sigma 1, and sigma 2 receptor binding (Ki values) for these compounds.±í1×ܽáÁËÕâЩ»¯ºÏÎïµÄ³õÆÚÎĿ⹤×÷ÒÔ¼°Õë¶Ô¦Ê°¢Æ¬ÊÜÌå¡¢sigma 1ºÍsigma 2ÊÜÌå½áºÏµÄÊÔÑéɸѡµÄÕûÌå×´¿ö¡£
5Â¥2011-07-19 17:05:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÑÌÔÆÌýÓê µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ÉúÎïÒ½Ò©µ÷¼Á£üSCIÖпÆÔºÈýÇøÒ»×÷+¶àÏî¿ÆÑгɹû +3 likangxing 2026-04-07 5/250 2026-04-07 13:13 by guanxin1001
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-02 14/700 2026-04-07 12:52 by Sammy2
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Àí¹¤085601²ÄÁϹ¤³Ì303·ÖÇóµ÷¼Á +8 a1708 2026-04-06 8/400 2026-04-07 11:20 by Ê«Óë×ÔÓÉ
[¿¼ÑÐ] Çóµ÷¼Á +3 ÔÂ@163.com 2026-04-07 3/150 2026-04-07 11:19 by aidndnjck
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí³µÁ¾×¨Ë¶×Ü·Ö 281 Çóµ÷¼Á +4 Éϰ¶Ñо¿Éú. 2026-04-02 4/200 2026-04-07 09:52 by ¼ÓÓÍÏòδÀ´°¡
[¿¼ÑÐ] 085100½¨Öþѧ ѰÇó¿çרҵµ÷¼Á Ò»Ö¾Ô¸ÄÏ´ó294·Ö У¼¶Ê¡¼¶¹ú¼Ò¼¶½±ÏîÈô¸É ̤ʵ¿Ï¸É +3 1021075758 2026-04-06 4/200 2026-04-07 09:23 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 312Çóµ÷¼Á +4 LR6 2026-04-06 4/200 2026-04-07 08:42 by jp9609
[¿¼ÑÐ] һ־Ը̫ԭÀí¹¤´óѧ¼ÆËã»ú¼¼Êõר˶348£¬Çóµ÷¼ÁÖ¸µ¼ +3 nexious 2026-04-05 3/150 2026-04-07 08:19 by jp9609
[¿¼ÑÐ] 085600£¬321·ÖÇóµ÷¼Á +14 ´ó²öС×Ó 2026-04-04 15/750 2026-04-06 22:58 by qlm5820
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +5 СÁõͬѧ߹߹ 2026-04-06 5/250 2026-04-06 18:34 by sherry_1901
[¿¼ÑÐ] 0703×Ü·Ö331Çóµ÷¼Á +12 ZY-05 2026-04-04 16/800 2026-04-06 17:54 by lijunpoly
[¿¼ÑÐ] ¹¤¿Æ370Çóµ÷¼Á +3 äçÐļ弦µ° 2026-04-05 3/150 2026-04-06 10:55 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 085600µ÷¼Á +4 1amJJ 2026-04-02 4/200 2026-04-04 21:53 by hemengdong
[¿¼ÑÐ] 359Çóµ÷¼Á +7 hhhhaaaa$ 2026-04-04 7/350 2026-04-04 18:49 by imissbao
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö +15 ˶ÐǸ° 2026-04-03 15/750 2026-04-04 01:01 by userper
[¿¼ÑÐ] 322Çóµ÷¼Á +6 FZAC123 2026-04-03 6/300 2026-04-03 22:23 by ¿ÆÑÐСר¼Ò
[¿¼ÑÐ] ¿¼Ñе÷¼Á +8 ²»°®ºÈÒûÁÏ 2026-04-03 8/400 2026-04-03 16:40 by Mistake-J
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +6 ´ó²öС×Ó 2026-04-02 6/300 2026-04-02 21:54 by dongzh2009
[¿¼ÑÐ] 314Çóµ÷¼Á +11 1xiaojun23 2026-03-31 12/600 2026-04-02 12:31 by 1xiaojun23
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +10 Eujd1 2026-03-31 11/550 2026-04-01 11:23 by ivanqyq
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û